De-escalation: Trump announces generic moratorium, 100% tariffs by 2028
President Donald Trump announced on Tuesday that imported generic drugs will face no tariffs for two years starting August 1, 2026, before steep increases kick in. He said tariffs would rise to 100% in August 2028 and then to 200% by 2029.
Generic drugs are off‑patent copies of brand‑name medicines, and tariffs are taxes on imports. Trump framed the plan as a way to push pharmaceutical manufacturing back to the U.S. and reduce reliance on overseas suppliers.
Multiple outlets detailed the timeline: zero tariffs from August 1, 2026, through July 31, 2028; a 100% tariff beginning in August 2028; and a further jump to 200% in 2029. CNBC, Politico, Fox Business, and Supply Chain Dive all described this phased approach.
One trade publication, Pharmaceutical Executive, reported a shorter zero‑tariff window “through August 2026,” which conflicts with the two‑year moratorium cited by most other outlets. The broader consensus points to a full two years of duty‑free treatment before hikes begin.
What’s next: the duty‑free period starts August 1, 2026; the 100% tariff is slated for August 2028; and the 200% rate is targeted for 2029. No additional implementation steps or dates were specified in the reports.
Synthesized from 15 sources
FinanceIndiatodayTimesofindiaMuscatdailyNdtvBiostockCBS NewsFiercepharmaChina BriefingPoliticoLos Angeles TimesReutersUSA TodaySpotlightpaNew York Times
AI-synthesized from multiple reported sources
In the app
Read this update in Frameshift
Four stories are free on the web. The full Vault, with every timeline and brief, is in the app.